Viewing Study NCT01421004


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-03-06 @ 1:21 AM
Study NCT ID: NCT01421004
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2011-08-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module